|Podcasts|June 24, 2021

Predicting Supply Risk and Disruption

Author(s)Nicholas Saraceno, Senior Editor, Michael Christel

C-suite executive shares knowledge surrounding data security and risk mitigation

Atul Vashishta, founder and CEO of Supply Wisdom, a company that delivers continuous risk intelligence, discusses his story in starting up the business, how he identified early risk indicators for Covid disruption, industry approaches to cybersecurity and plenty more.

The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Related to this article

CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813

November 4th, 2026

Pharma Pulse: CVS Health to Break in Two, Bayer Weighs MFN

In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.

Sep 2, 2020 Sunnyvale / CA / USA - GoodRx Card placed in front of the GoodRx app open on a smartphone; GoodRx is a startup company providing prescription drugs discounts and a telemedicine platform. | © Sundry Photography - stock.adobe.com 377582664

October 29th, 2026

Pharma Pulse: GoodRx Opens Employer GLP-1 Channel, Lilly Fends Off Novo Ad Challenge, PCMA Takes Aim at Wholesalers

In this week’s Pharma Pulse, GoodRx expands an employer offering built on manufacturer pricing for GLP-1 obesity drugs, a federal judge declines to block Lilly’s comparative Zepbound ads, and the PBM industry’s trade group turns the vertical integration debate toward drug wholesalers.

Cencora headquarters in Conshohocken, Pennsylvania, USA, on November 6, 2023. Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company. | JHVEPhoto - stock.adobe.com 1135295616

October 22nd, 2026

Pharma Pulse: Cencora to Acquire AON, Amazon and Google Back ePA Expansion

In this week's Pharma Pulse, Cencora agrees to acquire American Oncology Network, five major employers back electronic prior authorization for self-funded health plans and FDA finalizes its guidance on prescription drug apps and software.

Predicting Supply Risk and Disruption

Related to this article

Trending on Pharmaceutical Commerce

How CMS’ Final Negotiation Rule Treats New Drug Formulations

Bob Cochran: Direct-to-Patient Was a 'Watershed Moment' for Commercial Trade

The AI Efficiency Trap: Why Faster Tasks Alone Won’t Transform Life Sciences

2026 Brought Progress on Drug Prices. What Will It Take to Improve Patient Access in 2027?

Big Three Distributors Lean on Specialty for Profit Growth